SCHEMBL17754449

SCHEMBL17754449

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc5cc(-c6cccc(-c7nc(-c8ccccc8)nc(-c8cccc9ccccc89)n7)c6)ccc45)cc3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ MAPT P10636 4/20 0.47
▸ HPGD P15428 4/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ TSHR P16473 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ NFKB2 Q00653 1/20 0.47
▸ RELA Q04206 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ CA12 O43570 2/20 0.46
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ CA9 Q16790 2/20 0.46
▸ HSD17B1 P14061 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25798792 0.96 CA12 (0.48) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL17655975 0.95 CA12 (0.50) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL25816357 0.94 CA12 (0.47) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL26432295 0.94 CA12 (0.49) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL27455831 0.94 CA12 (0.48) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL16716612 0.94 MAPT (0.51) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL25621506 0.93 MAPT (0.46) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL25798740 0.93 CA12 (0.48) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL27257072 0.93 ALDH1A1 (0.46) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL17754450 0.92 HSD17B1 (0.49) ALDH1A1MAPTHPGDKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9882145-B2 Hetero ring compound and organic light emitting diode comprising same LG CHEM, LTD. (KR) 2018-01-30 — — US disclosed
US-9882145-B2 Hetero ring compound and organic light emitting diode comprising same LG CHEM, LTD. (KR) 2018-01-30 — — US disclosed
US-20160141514-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2016-05-19 — — US disclosed
US-20160141514-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2016-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160141514-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME CRY1, CRY2, PER2 ALDH1A1 962/4885MAPT 329/4885HPGD 3775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback